Clover Health Investments (CLOV) Earnings Analysis
Clover Health Investments (CLOV) has no confirmed upcoming earnings date. Last quarter (2026-02-26) it beat with EPS -0.05 USD vs -0.10212 USD est (+51%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -41.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLOV next report earnings?
No confirmed upcoming earnings date is currently scheduled for CLOV. This page updates as the calendar is published.
CLOV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.05 USD | -0.10212 USD | +51% | Beat |
| 2025-02-27 | -0.04 USD | -0.07 USD | +42.9% | Beat |
| 2024-08-05 | 0.01 USD | -0.05 USD | +120% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
CLOV valuation and analyst view
| Trailing P/E | -41.96 |
|---|---|
| Trailing EPS | -0.10904 USD |
| Price / book | 7.18 |
| Dividend yield | 0.00% |
| Market cap | 2.47B |
| Analyst consensus | Hold (1 buy / 5 hold / 3 sell) |
| Avg price target | 4.82 USD |
Related research pages
Frequently asked questions
When is Clover Health Investments (CLOV)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CLOV. This page updates as the calendar is published.
Did CLOV beat earnings last quarter?
In its 2026-02-26 report, CLOV posted EPS of -0.05 USD versus a -0.10212 USD estimate — a beat of 51%.
What is CLOV's earnings track record?
Over the last 3 reported quarters with consensus data, CLOV beat estimates 3 times (100%).
What is CLOV's current P/E ratio and EPS?
CLOV trades at a trailing P/E of -41.96 on trailing EPS of -0.10904385813834705 USD.
What do analysts rate CLOV?
Analyst consensus is "Hold" across 9 ratings (0 strong buy, 1 buy, 5 hold, 3 sell, 0 strong sell). Average 12-month price target: 4.82 USD.